Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial

BACKGROUND: In the ANRS EASIER trial where treatment-experienced patients switched from enfuvirtide (ENF) to raltegravir (RAL), a high incidence of transaminase elevation was reported in the RAL arm. METHODS: We compared the incidence of emergent liver enzyme elevations (LEE) of grade 2 or more amon...

Descripción completa

Detalles Bibliográficos
Autores principales: de Castro, Nathalie, Braun, Joséphine, Charreau, Isabelle, Lafeuillade, Alain, Viard, Jean-Paul, Allavena, Clotilde, Aboulker, Jean-Pierre, Molina, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818923/
https://www.ncbi.nlm.nih.gov/pubmed/27042193
http://dx.doi.org/10.1186/s12981-016-0101-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818923/
https://www.ncbi.nlm.nih.gov/pubmed/27042193
http://dx.doi.org/10.1186/s12981-016-0101-3

Ejemplares similares